Metabolic Syndrome Risk after Gestational Diabetes: A Systematic Review and Meta-Analysis
Open accessThe DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Abstract
BACKGROUND: A number of studies have been conducted to investigate the risk of metabolic syndrome (MS) after gestational diabetes mellitus (GDM), but the results are contradictory. Accordingly, we performed a systematic review and meta-analysis to assess the association between these two conditions. The aim was to better understand the risks of MS with prior gestational diabetes. METHODS: Pubmed, ISI Web of Science, and Cochrane databases from September 1, 1979 to July 11, 2013 were searched to identify relevant studies. 17 studies containing 5832 women and 1149 MS events were included. We calculated the odds ratio (OR) with 95% confidence interval (CI) in analysis for each study using a random-effect or fixed-effect model. We also determined heterogeneity among these 17 articles and their publication bias. RESULTS: Women with a history of gestational diabetes had a significantly higher risk of MS than those who had a normal pregnancy (OR, 3.96; 95% CI, 2.99 to 5.26), but had significant heterogeneity (I (2) = 52.6%). The effect remained robust (OR, 4.54; 95% CI, 3.78-5.46) in the subgroup of Caucasians, but no association (OR, 1.28; 95% CI, 0.64-2.56) was found in Asians. Heterogeneity was reduced (body mass index (BMI) matched group I (2) = 14.2%, BMI higher in the GDM group I (2) = 13.2%) in the subgroup of BMI. In addition, mothers with higher BMI in the GDM group had higher risk of MS than those in the BMI matched group (BMI higher in GDM group OR, 5.39; 95% CI, 4.47-6.50, BMI matched group OR, 2.53; 95% CI, 1.88-3.41). CONCLUSIONS: This meta-analysis demonstrated increased risk of MS after gestational diabetes. Therefore, attention should be given to preventing or delaying the onset of MS in GDM mothers, particularly in Caucasian and obese mothers.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Meta-analyses indicate that women with a history of GDM have an approximately 2.5-fold higher risk of developing metabolic syndrome [9]”
From Postpartum Body Mass Index Change Is Associated with Incident Dysglycemia in Women with a History of Gestational Diabetes Mellitus: A Prospective Cohort Study (2026) · cites this paper as [9]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Not surprisingly, GDM is associated with postpartum metabolic perturbation and an increased risk of CVD [57-59].”
From Gestational Diabetes Mellitus: Diagnostic Approaches and Maternal-Offspring Complications (2022) · cites this paper as [59]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Standards of Medical Care in Diabetes
Power, D. (2006) · Diabetes Care · doi:10.2337/diacare.29.02.06.dc05-1593 · Cited by 8,673
Cardiovascular Morbidity and Mortality Associated With the Metabolic Syndrome
Isomaa, B., Almgren, P., Tuomi, T., Forsén, B., Lahti, K., Nissén, M., Taskinen, M.-R., & Groop, L. (2001) · Diabetes Care · doi:10.2337/diacare.24.4.683 · Cited by 4,760 · cited 1×
“Moreover, the clinical impact of MS has been considered a cause of cardiovascular morbidity and mortality [11].”
BackgroundType 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis
Bellamy, L., Casas, J.-P., Hingorani, A. D., & Williams, D. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60731-5 · Cited by 3,253 · cited 1×
“’’ A meta-analysis conducted in 2009 demonstrated that women who have had GDM have at least sevenfold increased risk of developing T2DM in the future than those who have had normal pregnancy [34].”
MethodObesity and insulin resistance
Kahn, B. B., & Flier, J. S. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10842 · Cited by 3,225
Standards of medical care in diabetes—2011
American Diabetes Association (2011) · Diabetes Care · doi:10.2337/dc11-s011 · Cited by 2,880
Buchanan, T. A., & Xiang, A. H. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200524531 · Cited by 2,123
Ford, E. S. (2005) · Diabetes Care · doi:10.2337/diacare.28.7.1769 · Cited by 1,710 · cited 1×
“In 2005, Ford [31] reported that MS is associated with twofold to threefold increased risk of T2DM and premature CVDs.”
BackgroundGrundy, S. M. (2008) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.107.151092 · Cited by 1,563 · cited 1×
“Metabolic syndrome (MS) is considered as the concomitant clustering of central obesity, hypertriglyceridemia, low high-density lipoprotein (HDL) cholesterol, hypertension, and dysglycemia [8,9].”
BackgroundAmerican Diabetes Association (2004) · Diabetes Care · doi:10.2337/diacare.27.2007.s88 · Cited by 916
Association of Sedentary Behaviour with Metabolic Syndrome: A Meta-Analysis
Edwardson, C. L., Gorely, T., Davies, M. J., Gray, L. J., Khunti, K., Wilmot, E. G., Yates, T., & Biddle, S. J. H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0034916 · Cited by 535 · cited 1×
“The incidence of T2DM and MS is rising rapidly worldwide because of the prevalence of unhealthy diet and physical inactivity [28,29,30].”
Background
Cited by
Gestational Diabetes Mellitus: Diagnostic Approaches and Maternal-Offspring Complications
Moon, J. H., & Jang, H. C. (2022) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2021.0335 · Cited by 377
Retnakaran, R., & Shah, B. R. (2017) · Diabetes Care · doi:10.2337/dc16-1400 · Cited by 167
Alonso‐Magdalena, P., García‐Arévalo, M., Quesada, I., & Nadal, Á. (2015) · Endocrinology · doi:10.1210/en.2014-1952 · Cited by 141
Mwanri, A. W., Kinabo, J., Ramaiya, K., & Feskens, E. J. M. (2015) · Tropical Medicine & International Health · doi:10.1111/tmi.12521 · Cited by 128
The pharmacological management of metabolic syndrome
Rask Larsen, J., Dima, L., Correll, C. U., & Manu, P. (2018) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2018.1429910 · Cited by 113
“Of great concern is that its prevalence is increasing among children and young adults [14,15], particularly in women, in whom it has been associated with increased risk for gestational diabetes, gestational hypertension, and sexual dysfunction [16,17].”
BackgroundShostrom, D. C. V., Sun, Y., Oleson, J. J., Snetselaar, L. G., & Bao, W. (2017) · Frontiers in Endocrinology · doi:10.3389/fendo.2017.00144 · Cited by 96
“Several studies also suggest that GDM is associated with atherosclerosis (2), metabolic syndrome (3, 4), endothelial and cardiac dysfunction (3), and other intermediate cardiovascular morbidities (5).”
BackgroundSheiner, E., Kapur, A., Retnakaran, R. R., Hadar, E., Poon, L. C., McIntyre, D. H., Divakar, H., Staff, A. C., Narula, J., Kihara, A., et al. (2019) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.12926 · Cited by 102
The Emerging Role of Biomarkers in the Diagnosis of Gestational Diabetes Mellitus
Rodrigo, N., & Glastras, S. J. (2018) · Journal of Clinical Medicine · doi:10.3390/jcm7060120 · Cited by 84
Hyperglycemia in pregnancy and its implications for a woman’s future risk of cardiovascular disease
Retnakaran, R. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.04.008 · Cited by 81
Fuchs, O., Sheiner, E., Meirovitz, M., Davidson, E., Sergienko, R., & Kessous, R. (2016) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-016-4275-7 · Cited by 82
Gestational Diabetes Mellitus: Mechanisms Underlying Maternal and Fetal Complications
Lee, J., Lee, N. K., & Moon, J. H. (2025) · Endocrinology and Metabolism · doi:10.3803/enm.2024.2264 · Cited by 101
“Women with GDM exhibit a higher risk of diabetes-related complications, particularly an increased risk of CVD [21-25].”
Mitochondrial dysfunction in the fetoplacental unit in gestational diabetes mellitus
Sobrevía, L., Valero, P., Grismaldo, A., Villalobos-Labra, R., Pardo, F., Subiabre, M., Armstrong, G. A., Toledo, F., Vega, S., Cornejo, M., et al. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2020.165948 · Cited by 82
Pathirana, M. M., Lassi, Z. S., Alì, A., Arstall, M. A., Roberts, C. T., & Andraweera, P. H. (2020) · Endocrine · doi:10.1007/s12020-020-02492-1 · Cited by 83
Prediction models for the risk of gestational diabetes: a systematic review
Lamain – de Ruiter, M., Kwee, A., Naaktgeboren, C. A., Franx, A., Moons, K. G. M., & Koster, M. P. H. (2017) · Diagnostic and Prognostic Research · doi:10.1186/s41512-016-0005-7 · Cited by 62
“The mother is at high risk to develop diabetes mellitus type II within 5 years after pregnancy [7 – 9], and her child is at increased risk of developing childhood obesity and metabolic syndrome [10 – 12].”
Gestational diabetes mellitus and interpregnancy weight change: A population-based cohort study
Sorbye, L. M., Skjaerven, R., Klungsoyr, K., & Morken, N. H. (2017) · PLOS Medicine · doi:10.1371/journal.pmed.1002367 · Cited by 60
Lifestyle interventions in pregnancy targeting GDM prevention: looking ahead to precision medicine
Sparks, J. R., Ghildayal, N., Hivert, M., & Redman, L. M. (2022) · Diabetologia · doi:10.1007/s00125-022-05658-w · Cited by 78
“These includematernal development of type 2 diabetes [6–8], the metabolic syndrome [9, 10] and CVD [11–14].”
BackgroundObuchowska, A., Gorczyca, K., Standyło, A., Obuchowska, K., Kimber-Trojnar, Ż., Wierzchowska-Opoka, M., & Leszczyńska‐Gorzelak, B. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158253 · Cited by 63
“Some evidence suggests that MS and GDM may have a common genetic basis [99].”
BackgroundPolyphenol-rich foods and risk of gestational diabetes: a systematic review and meta-analysis
Pham, N. M., Vuong, V., & Lee, A. H. (2018) · European Journal of Clinical Nutrition · doi:10.1038/s41430-018-0218-7 · Cited by 64
Benhalima, K., Crombrugge, P. V., Moyson, C., Verhaeghe, J., Vandeginste, S., Verlaenen, H., Vercammen, C., Maes, T., Dufraimont, E., Block, C. E. M. D., et al. (2020) · Acta Diabetologica · doi:10.1007/s00592-019-01469-5 · Cited by 61
Wiedemann, P., Sorgente, N., Bekhor, C., Patterson, R., Tran, T., & Ryan, S. J. (1985) · PubMed · Cited by 54
Zhang, X., Zhang, R., Cheng, L., Wang, Y., Ding, X., Fu, J., Dang, J., Moore, J., & Li, R. (2020) · Sleep Medicine · doi:10.1016/j.sleep.2020.05.014 · Cited by 50
High risk of metabolic syndrome after delivery in pregnancies complicated by gestational diabetes
Shen, Y., Li, W., Leng, J., Zhang, S., Liu, H., Li, W., Wang, L., Tian, H., Chen, J., Qi, L., et al. (2019) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2019.03.030 · Cited by 49
Prevalence of newly detected diabetes in pregnancy in Qatar, using universal screening
Bashir, M., Abdel‐Rahman, M. E., Aboulfotouh, M. E., Eltaher, F., Omar, K., Babarinsa, I., Appiah-Sakyi, K., Sharaf, T., Azzam, E., Abukhalil, M. H., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0201247 · Cited by 53
Wambua, S., Singh, M., Okoth, K., Snell, K. I. E., Riley, R. D., Yau, C., Thangaratinam, S., Nirantharakumar, K., Crowe, F. L., & on behalf of the MuM-PreDiCT Group (2024) · BMC Medicine · doi:10.1186/s12916-024-03284-4 · Cited by 50
Gestational diabetes and long-term risk for dyslipidemia: a population-based historical cohort study
Chodick, G., Tenne, Y., Barer, Y., Shalev, V., & Elchalal, U. (2020) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2019-000870 · Cited by 51
Atkinson, S. A., Maran, A., Dempsey, K., Perreault, M., Vanniyasingam, T., Phillips, S. M., Hutton, E. K., Mottola, M. F., Wahoush, O., Xie, F., et al. (2022) · Nutrients · doi:10.3390/nu14040810 · Cited by 52
Zhang, Q.-Q., Li, X., Liu, X., Dong, M., Xiao, J., Wang, J., Zhou, M., Wang, Y., Ning, D., Ma, W., et al. (2019) · Chemosphere · doi:10.1016/j.chemosphere.2019.125732 · Cited by 45
Tranidou, A., Dagklis, T., Tsakiridis, I., Siargkas, A., Apostolopoulou, A., Mamopoulos, A., Goulis, D. G., & Chourdakis, M. (2021) · Journal of Endocrinological Investigation · doi:10.1007/s40618-020-01464-6 · Cited by 43
Metsälä, J., Stach‐Lempinen, B., Gissler, M., Eriksson, J. G., & Koivusalo, S. B. (2015) · Paediatric and Perinatal Epidemiology · doi:10.1111/ppe.12248 · Cited by 53
Gestational diabetes mellitus may be associated with increased risk of breast cancer
Park, Y., O’Brien, K. M., Zhao, S., Weinberg, C. R., Baird, D. D., & Sandler, D. P. (2017) · British Journal of Cancer · doi:10.1038/bjc.2017.34 · Cited by 41
“…mellitus (GDM) is associated with adverse pregnancy outcomes (Agha-Jaffar et al, 2016) and long-term adverse health conditions, including type 2 diabetes (Bellamy et al, 2009), metabolic syndrome (Xu et al, 2014), cardiovascular diseases (Li et al, 2014) and some cancers (Tong et al, 2014).”
BackgroundThe Role of Lifestyle Interventions in the Prevention and Treatment of Gestational Diabetes Mellitus
Zakaria, H., Abusnana, S., Mussa, B. M., Dhaheri, A. S. A., Stojanovska, L., Mohamad, M. N., Saleh, S. T., Ali, H. I., & Ismail, L. C. (2023) · Medicina · doi:10.3390/medicina59020287 · Cited by 52
Gestational diabetes mellitus and quality of life during the third trimester of pregnancy
Pantzartzis, K. A., Manolopoulos, P. P., Paschou, S. Α., Kazakos, K., Kotsa, K., & Goulis, D. G. (2019) · Quality of Life Research · doi:10.1007/s11136-018-2090-2 · Cited by 48
Yefet, E., Schwartz, N., Sliman, B., Ishay, A., & Nachum, Z. (2019) · Cardiovascular Diabetology · doi:10.1186/s12933-019-0881-6 · Cited by 43
Sørbye, L. M., Cnattingius, S., Skjærven, R., Klungsøyr, K., Wikström, A., Kvalvik, L. G., & Morken, N. (2020) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.16364 · Cited by 41
Lorenzo, P. I., Martín‐Montalvo, A., Cobo‐Vuilleumier, N., & Gauthier, B. R. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20246171 · Cited by 41
Hu, Q., Wang, D., Yue, D., Xu, C., Hu, B., Cheng, P., Zhai, Y., Mai, H., Li, P., Gong, J., et al. (2020) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2020.143176 · Cited by 38
Munang, Y. N., Noubiap, J. J., Danwang, C., Sama, J. D., Azabji‐Kenfack, M., Mbanya, J. C., & Sobngwi, E. (2017) · BMC Research Notes · doi:10.1186/s13104-017-2944-7 · Cited by 36
Retnakaran, R. R., & Shah, B. R. (2020) · Diabetes Care · doi:10.2337/dc20-1037 · Cited by 37
Eftekharzadeh, A., Khamseh, M. E., Farshchi, A., & Malek, M. (2016) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2015.0065 · Cited by 33
The risk of metabolic syndrome after gestational diabetes mellitus – a hospital-based cohort study
Vilmi‐Kerälä, T., Palomäki, O., Vainio, M., Uotila, J. T., & Palomäki, A. (2015) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-015-0038-z · Cited by 41
“In recent decades, the prevalence of MetS has rapidly increased in parallel with sedentary lifestyles [6], leading to major healthcare costs.”
BackgroundResultInfluentialValizadeh, M., Alavi‐Naeini, N., Mazloomzadeh, S., Piri, Z. A., & Amirmoghaddami, H. (2015) · Intern J Endocrinol Metab · doi:10.5812/ijem.21696 · Cited by 35
“However, these patients will be at a higher risk for T2DM and metabolic syndrome (MetS) in the coming years (2, 8, 9).”
BackgroundBogdanet, D., Reddin, C., Macken, E., Griffin, T. P., Fhelelboom, N., Biesty, L., Thangaratinam, S., Dempsey, E. M., Crowther, C. A., Galjaard, S., et al. (2019) · Diabetologia · doi:10.1007/s00125-019-4935-9 · Cited by 33
Manta-Vogli, P. D., Schulpis, K. H., Dotsikas, Y., & Loukas, Y. L. (2019) · Clinical Nutrition · doi:10.1016/j.clnu.2019.10.025 · Cited by 37
Muhwava, L. S., Murphy, K., Zarowsky, C., & Levitt, N. S. (2018) · BMC Health Services Research · doi:10.1186/s12913-018-3175-x · Cited by 37
Erjavec, K., Poljičanin, T., & Matijević, R. (2016) · Journal of Pregnancy · doi:10.1155/2016/2670912 · Cited by 28
Park, S., Lee, J. L., Jang, I., & Kim, Y. (2018) · Journal of Clinical Nursing · doi:10.1111/jocn.14539 · Cited by 37
Morris, M. A., Hutchinson, J., Gianfrancesco, C., Alwan, N. A., Carter, M. C., Scott, E. M., & Cade, J. E. (2019) · Nutrients · doi:10.3390/nu12010003 · Cited by 30
“GDM mothers are at increased risk of subsequent T2D, cardiovascular disorders, and metabolic syndrome [28].”
BackgroundNouhjah, S., Shahbazian, H. B., Shahbazian, N., Jahanshahi, A., Jahanfar, S., & Cheraghian, B. (2017) · Journal of Diabetes Research · doi:10.1155/2017/9786436 · Cited by 33
“Incidence of GDM is increasing and this rise is attributed to obesity, type 2 diabetes andmetabolic syndrome epidemic, advancing maternal age of pregnancy, and implementation of newly diagnosed criteria [1, 7, 8].”
Bugatto, F., Quintero‐Prado, R., Visiedo, F., Vilar‐Sánchez, J. M., Figueroa-Quiñones, A., López‐Tinoco, C., Torrejón, R., & Bartha, J. L. (2017) · Reproductive Sciences · doi:10.1177/1933719117698576 · Cited by 31
“These proinflammatory and dyslipidemic states may be a pathophysiological link between GDM and future type 2 diabetes and metabolic syndrome, including CVD.(10,11) It is also known that subclinical inflammation and vascular dysfunction are present in nonpregnant women with previous gestational diabetes.”
BackgroundPei, L., Xiao, H., Lai, F., Li, Z., Li, Z., Yue, S., Chen, H., Li, Y., & Cao, X. (2020) · Lipids in Health and Disease · doi:10.1186/s12944-020-01398-1 · Cited by 32
Self-citationMetabolic syndrome in Finnish women 7 years after a gestational diabetes prevention trial
Puhkala, J., Raitanen, J. A., Kolu, P., Tuominen, P. P. A., Husu, P., & Luoto, R. M. (2017) · BMJ Open · doi:10.1136/bmjopen-2016-014565 · Cited by 31
Benhalima, K., Verstraete, S., Muylle, F., Decochez, K., Devlieger, R., Crombrugge, P. V., Verhaegen, A. A., Wens, J., & Mathieu, C. (2017) · International Journal of Endocrinology · doi:10.1155/2017/3971914 · Cited by 27
“Women with a history of GDM are also at increased risk to develop the metabolic syndrome [9].”
BackgroundNouhjah, S., Shahbazian, H. B., Shahbazian, N., Jahanfar, S., Jahanshahi, A., Cheraghian, B., Mohammadi, Z. D., Ghodrati, N., & Houshmandi, S. (2017) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2017.12.027 · Cited by 28
García‐Patterson, A., Balsells, M., Solà, I., Gich, I. J., & Corcoy, R. (2022) · Diabetic Medicine · doi:10.1111/dme.14998 · Cited by 27
Naser, W., Adam, I., Rayis, D. A., Ahmed, M., & Hamdan, H. Z. (2019) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-019-2429-x · Cited by 27
“Women with GDM are vulnerable to develop metabolic syndrome/type 2 diabetes later in life [3, 4].”
BackgroundBar, J., Weiner, E., Levy, M., & Gilboa, Y. (2021) · American Journal of Obstetrics & Gynecology MFM · doi:10.1016/j.ajogmf.2021.100473 · Cited by 29
Genetic risk factors associated with gestational diabetes in a multi-ethnic population
Benny, P. A., Ahn, H. J., Burlingame, J. M., Lee, M., Miller, C. B., Chen, J. L., & Urschitz, J. (2021) · PLoS ONE · doi:10.1371/journal.pone.0261137 · Cited by 26
Endometriosis and gestational diabetes mellitus risk: a systematic review and meta-analysis
Pérez-López, F. R., Martínez‐Domínguez, S. J., Viñas, A., Pérez-Tambo, R., Lafita-López, A., Lajusticia, H., Chedraui, P. A., & for the Health Outcomes and Systematic Analyses (HOUSSAY) Project (2017) · Gynecological Endocrinology · doi:10.1080/09513590.2017.1397115 · Cited by 26
“Prospective studies with long-term follow up suggest that GDM has short- and long-term negative consequences for both mother and offspring [7,8].”
BackgroundGhajari, H., Nouhjah, S., Shahbazian, H. B., Valizadeh, R., & Tahery, N. (2017) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2017.03.035 · Cited by 23
Sudasinghe, B. H., Ginige, P. S., & Wijeyaratne, C. N. (2016) · Ceylon Medical Journal · doi:10.4038/cmj.v61i4.8379 · Cited by 22
“After delivery, women with GDM often have an increased risk of developing metabolic syndrome, which is also seen in South Asian women [1, 6-8].”
BackgroundGadve, S. S., Chavanda, S., Mukherjee, A. D., Aziz, S., Joshi, A., & Patwardhan, M. (2021) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/ijem.ijem_57_21 · Cited by 22
“[3] In the long term, GDM increases the risk of T2DM and metabolic syndrome in later years.[23,24] Shriraam et al.”
BackgroundO-GlcNAc transferase contributes to sex-specific placental deregulation in gestational diabetes
Cui, Y., Cruz, M., Palatnik, A., & Stichelen, S. O.-V. (2022) · Placenta · doi:10.1016/j.placenta.2022.11.006 · Cited by 26
Jelsma, J. G. M., van Poppel, M. N. M., Smith, B. J., Cinnadaio, N., Bauman, A. E., Tapsell, L. C., Cheung, N. W., & van der Ploeg, H. P. (2017) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2942 · Cited by 23
“Women with a history of GDM also have an almost 4‐fold increased risk of the metabolic syndrome.(4) Being overweight or obese is another important although modifiable risk factor for T2DM(5) and metabolic syndrome.”
BackgroundMercier, R., Perron, J., Weisnagel, S. J., & Robitaille, J. (2018) · European Journal of Nutrition · doi:10.1007/s00394-018-1669-2 · Cited by 25
“Indeed, women with prior GDM are at higher risk of subsequent cardiovascular disease [6–9], metabolic syndrome [10] and type 2 diabetes (T2D) [2, 11, 12].”
BackgroundJamilian, M., Samimi, M., Ebrahimi, F. A., Aghadavod, E., Mohammadbeigi, R., Rahimi, M., & Asemi, Z. (2017) · Biological Trace Element Research · doi:10.1007/s12011-017-1045-8 · Cited by 23
“These pro-inflammatory cytokines may be a pathophysiological link between GDM and future type 2 diabetes andmetabolic syndrome, including cardiovascular diseases [31, 32].”
BackgroundPotzel, A. L., Gar, C., Banning, F., Sacco, V., Fritsche, A., Fritsche, L., Müssig, K., Dauben, L., Seissler, J., & Lechner, A. (2022) · PLOS ONE · doi:10.1371/journal.pone.0267258 · Cited by 20
“A history of GDM indicates a tenfold higher risk for type 2 diabetes later in life [2] and an increased risk for related cardiometabolic disturbances [3] starting in the years following delivery [4].”
BackgroundVandyousefi, S., Goran, M. I., Gunderson, E. P., Khazaee, E., Landry, M. J., Ghaddar, R., Asigbee, F. M., & Davis, J. N. (2019) · Pediatric Obesity · doi:10.1111/ijpo.12515 · Cited by 24
“Children born to mothers with GDM are more likely to develop prediabetes, MetS, and increased adiposity later in life.(16,17) A longitudinal cohort of 6‐ to 11‐year‐old children showed that GDM offspring who were large for gestational age (LGA) had 3 to 5 times higher prevalence of MetS than non‐GDM children born appr…”
BackgroundObesity Affects Maternal and Neonatal HDL Metabolism and Function
Stadler, J. T., van Poppel, M. N. M., Wadsack, C., Holzer, M., Pammer, A., Simmons, D. S., Hill, D. J., Desoyé, G., Marsche, G., & DALI Core Investigator Group (2023) · Antioxidants · doi:10.3390/antiox12010199 · Cited by 20
Zaman, F., Nouhjah, S., Shahbazian, H. B., Shahbazian, N., Latifi, S. M., & Jahanshahi, A. (2018) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2018.04.014 · Cited by 20
A Systematic Review of the Prevalence of Gestational Diabetes in Norway
Behboudi-Gandevani, S., Parajuli, R., & Vaismoradi, M. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18041423 · Cited by 19
Potzel, A. L., Gar, C., Seißler, J., & Lechner, A. (2021) · JMIR mhealth and uhealth · doi:10.2196/26163 · Cited by 20
Roca-Rodríguez, M. D. M., López‐Tinoco, C., Fernández‐Deudero, Á., Murri, M., García-Palacios, M. V., García‐Valero, M. A., Tinahones, F. J., & Aguilar‐Diosdado, M. (2017) · Endocrinología Diabetes y Nutrición · doi:10.1016/j.endinu.2016.10.003 · Cited by 18
Xie, K., Zhang, Y., Wen, J., Chen, T., Kong, J., Zhang, J., Wu, X., Hu, C., Xu, B., Ji, C., et al. (2019) · Journal of Diabetes · doi:10.1111/1753-0407.12923 · Cited by 17
“Pregnant women with GDM have an increased risk of type 2 diabetes (T2D) and metabolic syndrome later in life.(3,4) Moreover, their offspring have a greater risk of obesity and T2D in childhood and adulthood, forming a vicious intergenerational cycle.”
BackgroundAlkazemi, D. U. Z., Alsouri, N., Zafar, T. A., & Kubow, S. J. (2022) · Nutrients · doi:10.3390/nu14245257 · Cited by 18
“During pregnancy, the body weight might increase by more than 20% [33], gestational diabetes may increase the risk of T2DM and MetS [34], and preeclampsia may predispose the woman to hypertension and CVD later in life [35].”
BackgroundNguyen, B., Tselovalnikova, T., & Drees, B. M. (2023) · Endocrine Practice · doi:10.1016/j.eprac.2023.10.133 · Cited by 16
Anzoategui, S., Gibbone, E., Wright, A., Nicolaides, K. H., & Charakida, M. (2022) · Ultrasound in Obstetrics and Gynecology · doi:10.1002/uog.24929 · Cited by 16
Hakkarainen, H., Huopio, H., Cederberg, H., Voutilainen, R., & Heinonen, S. T. (2018) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-018-1958-z · Cited by 20
The Impact of Preeclampsia and Gestational Diabetes on Future Maternal Cardiometabolic Health
Barrell, A. M., & Sferruzzi-Perri, A. N. (2025) · Acta Physiologica · doi:10.1111/apha.70113 · Cited by 16
Genetics and epigenetics in gestational diabetes contributing to type 2 diabetes
Kong, D., Kowalik, O., Garratt, E. S., Godfrey, K. M., Chan, S., & Teo, A. K. K. (2025) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2025.03.014 · Cited by 16
Su, M., Chao, A., CHANG, M.-Y., Chang, Y., Chen, C.-L., & Sun, J. (2021) · Journal of Nursing Research · doi:10.1097/jnr.0000000000000456 · Cited by 17
“Prepregnancy obesity and excessive weight gain during pregnancy are essential predictors of MS development in women with GDM (Shen et al., 2019; Xu et al., 2014), indicating the importance of effective weight control inMS prevention efforts.”
BackgroundRetnakaran, R. R., & Shah, B. R. (2021) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14479 · Cited by 18
Calancie, L., Brown, M. O., Choi, W. A., Caouette, J. L., McCann, J., Nam, E. Y., & Werner, E. F. (2025) · American Journal of Obstetrics & Gynecology MFM · doi:10.1016/j.ajogmf.2025.101606 · Cited by 15
Minschart, C., Lammertyn, A., Crombrugge, P. V., Moyson, C., Verhaeghe, J., Vandeginste, S., Verlaenen, H., Vercammen, C., Maes, T., Dufraimont, E., et al. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac599 · Cited by 14
Gestational Diabetes and Maternal Weight Management During and After Pregnancy
Chakkalakal, R. J., Hackstadt, A. J., Trochez, R. J., Gregory, R., & Elasy, T. A. (2019) · Journal of Women s Health · doi:10.1089/jwh.2018.7020 · Cited by 14
Chivese, T., Norris, S. A., & Levitt, N. S. (2019) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2019-000740 · Cited by 19
“…history of GDM (although these studies also included women with DIP, according to the WHO 2013 criteria) have double the risk for overall CVD 11 12 and coronary artery disease in the long term 12 and four times the risk for metabolic syndrome, 13 compared with women with normoglycemic pregnancies.”
Long‐term maternal cardiometabolic outcomes 22 years after gestational diabetes mellitus
Tutino, G., Tam, C. H., Ozaki, R., Yuen, L. Y., So, W. Y., Chan, M. H. M., Ko, G. T. C., Yang, X., Chan, J. C. N., Tam, W. H., et al. (2020) · Journal of Diabetes Investigation · doi:10.1111/jdi.13209 · Cited by 14
DNA Methylation in Gestational Diabetes and its Predictive Value for Postpartum Glucose Disturbances
Ballesteros, M., Gil-Lluís, P., Ejarque, M., Díaz-Perdigones, C. M., Martínez, L., Fernández‐Veledo, S., Vendrell, J. J., & Megía, A. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac462 · Cited by 15
Benevides, F. T., Júnior, E. A., Maia, C. S. C., Montenegro, R. M., & Carvalho, F. H. C. (2020) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767058.2020.1781808 · Cited by 14
“Information captured for each article included: [1] study design; [2] country; [3] population; [4] number of participants; [5] gestational age (weeks); [6] GDM tracking; [7]; definition of GDM [8]; prediction; [9] type of US; [10] measurement technique; [11] cutoff point for predicting GDM; and [12] conclusions.”
BackgroundBianchi, C., Gennaro, G., Brocchi, A., Minaldi, E., Prato, S. D., & Bertolotto, A. (2021) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2021.107854 · Cited by 13
Basha, A. S., Fram, K. M., Thekrallah, F. M., Irshaid, Z. A., Maswady, A. M., & Obeidat, Z. N. (2019) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-018-0635-0 · Cited by 11
Bélanger, M., Dugas, C., Perron, J., St-Yves, A., Rancourt-Bouchard, M., Weisnagel, S. J., & Robitaille, J. (2023) · Preventive Medicine Reports · doi:10.1016/j.pmedr.2023.102328 · Cited by 16
Raets, L., Marie, V., Crombrugge, P. V., Moyson, C., Verhaeghe, J., Vandeginste, S., Verlaenen, H., Vercammen, C., Maes, T., Dufraimont, E., et al. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.781384 · Cited by 12
“0 (5) % short and long-acting insulin 0.”
Bakiris, E., Luiro, K., Jokelainen, J. J., Morin-Papunen, L. C., Keinanen-Kiukaanniemi, S. M., Kaikkonen, K., Piltonen, T., Tapanainen, J. S., & AUVINEN, J. P. (2024) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1111/aogs.14861 · Cited by 14
Blair, R. A., Neves, J. S., Nicklas, J. M., Horn, C. E., Skurnik, G., & Seely, E. W. (2021) · American Journal of Perinatology · doi:10.1055/a-1674-5724 · Cited by 11
Beunen, K., Vercauter, L., Crombrugge, P. V., Moyson, C., Verhaeghe, J., Vandeginste, S., Verlaenen, H., Vercammen, C., Maes, T., Dufraimont, E., et al. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.973820 · Cited by 14
Petitclerc, I., Perron, J., Dugas, C., Mayer, T., Raymond, F., Marzo, V. D., Veilleux, A., & Robitaille, J. (2025) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-025-07584-2 · Cited by 11
Guía de práctica clínica de síndrome metabólico
González-Chávez, A., Gómez-Miranda, J. E., Elizondo-Argueta, S., Rangel-Mejía, M. D. P., & Sánchez-Zúñiga, M. D. J. (2019) · Alad · doi:10.24875/alad.19000381 · Cited by 17
Moffat, T., McKerracher, L., Oresnik, S., Atkinson, S. A., Barker, M. E., McDonald, S. D., Murray‐Davis, B., & Sloboda, D. M. (2021) · American Journal of Human Biology · doi:10.1002/ajhb.23604 · Cited by 9
“High GWG elevates risks for gestational diabetes and postpartum weight retention, increasing mothers' long-term noncommunicable disease (NCD) risks (Nicodemus, 2018; Xu et al., 2014) and is also associated with increased NCD risks in the offspring (Godfrey et al.”
BackgroundNicolaou, V., Soepnel, L. M., Huddle, K., Klipstein‐Grobusch, K., Levitt, N. S., & Norris, S. A. (2022) · PLoS ONE · doi:10.1371/journal.pone.0263529 · Cited by 10
Kosinski, C., Rossel, J., Gross, J., Helbling, C., Quansah, D. Y., Collet, T., & Puder, J. J. (2021) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2021-002382 · Cited by 9
Metadata
- Authors
- Xu, Y., Shen, S., Sun, L., Yang, H., Jin, B., & Cao, X.
- Affiliations
- Jiangsu Province Hospital (CN)
- Nanjing Medical University (CN)
- Corresponding author
- Sun, Lizhou
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2014-01-31
- Volume
- 9
- Issue
- 1
- Pages
- e87863
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3909287
- OpenAlex
- W1999269920
- Semantic Scholar
- dcf39153c088611e9b9ecf76681352ba84a3de7f
- Cited by
- 163
- References
- 46
- Citations by year
- 2026: 6 · 2025: 11 · 2024: 11 · 2023: 8 · 2022: 20 · 2021: 17 · 2020: 17 · 2019: 18 · 2018: 14 · 2017: 24 · 2016: 6 · 2015: 9 · 2014: 1
- FWCI
- 2.14
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Natural Science Foundation of China (81270710)
- Topics
- Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Birth, Development, and Health
- Keywords
- metabolic syndrome, gestational diabetes mellitus, body mass index, obesity, racial differences, Asian women, white women
- MeSH terms
- Female, Humans, Pregnancy, Risk Factors, Diabetes, Gestational, Metabolic Syndrome, Diabetes Complications
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.